Thermodynamics guided lead discovery and optimization

被引:99
作者
Ferenczy, Gyoergy G. [2 ]
Keserue, Gyoergy M. [1 ]
机构
[1] Gedeon Richter Plc, Discovery Chem, H-1103 Budapest, Hungary
[2] Sanofi Aventis CHINOIN, H-1045 Budapest, Hungary
关键词
PROTEIN-LIGAND-BINDING; VANT-HOFF; CALORIMETRIC ENTHALPIES; FUNDAMENTAL DIFFERENCE; CARBONIC-ANHYDRASE; DRUG DISCOVERY; DESIGN; ENTROPY; EFFICIENCY; AGONISTS;
D O I
10.1016/j.drudis.2010.08.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The documented unfavorable changes of physicochemical properties during lead discovery and optimization prompted us to investigate the present practice of medicinal chemistry optimization from a thermodynamic perspective. Basic principles of binding thermodynamics suggest that discriminating between enthalpy-driven and entropy-driven optimizations could be beneficial. We hypothesize that entropy-driven optimizations might be responsible for the undesirable trend observed in physicochemical properties. Consequently, we suggest that enthalpy-driven optimizations are preferred because they provide better quality compounds. Monitoring binding thermodynamics during optimization programs initiated from thermodynamically characterized hits or leads, therefore, could improve the success of discovery programs. Here, we summarize common industry practices for tackling optimization challenges and review how the assessment of binding thermodynamics could support medicinal chemistry efforts.
引用
收藏
页码:919 / 932
页数:14
相关论文
共 54 条
[1]   Fragment-based drug discovery: What has it achieved so fair? [J].
Alex, Alexander A. ;
Flocco, Maria M. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (16) :1544-1567
[2]   Non-additivity of Functional Group Contributions in Protein Ligand Binding: A Comprehensive Study by Crystallography and Isothermal Titration Calorimetry [J].
Baum, Bernhard ;
Muley, Laveena ;
Smolinski, Michael ;
Heine, Andreas ;
Hangauer, David ;
Klebe, Gerhard .
JOURNAL OF MOLECULAR BIOLOGY, 2010, 397 (04) :1042-1054
[3]   Ligand efficiency and fragment-based drug discovery [J].
Bembenek, Scott D. ;
Tounge, Brett A. ;
Reynolds, Chades H. .
DRUG DISCOVERY TODAY, 2009, 14 (5-6) :278-283
[4]   Binding thermodynamics at A(1) and A(2A) adenosine receptors [J].
Borea, PA ;
Dalpiaz, A ;
Varani, K ;
Gessi, S ;
Gilli, G .
LIFE SCIENCES, 1996, 59 (17) :1373-1388
[5]   Calorimetry and thermodynamics in drug design [J].
Chaires, Jonathan B. .
ANNUAL REVIEW OF BIOPHYSICS, 2008, 37 :135-151
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   Probing hot spots at protein-ligand binding sites: A fragment-based approach using biophysical methods [J].
Ciulli, Alessio ;
Williams, Glyn ;
Smith, Alison G. ;
Blundell, Tom L. ;
Abell, Chris .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) :4992-5000
[8]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[9]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[10]   Binding thermodynamics of 5-HT1A receptor ligands [J].
Dalpiaz, A ;
Borea, PA ;
Gessi, S ;
Gilli, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 312 (01) :107-114